Fredun Pharmaceuticals Ltd - 539730 - Closure of Trading Window
The Trading window for dealing of Securities of the Company will be closed from 01st Jan, 2024 till 48 hours after the end of Board Meeting in which unaudited Financial Results would be considered and approved. Fredun Pharmaceuticals Ltd - 539730 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper publication pursuant to Reg 30 and 47 read with Schedule III Part A of SEBI(LODR),2015 Fredun Pharmaceuticals Ltd - 539730 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation under Reg 39(3) of SEBI(LODR),2015 Fredun Pharmaceuticals Ltd - 539730 - Notice Of Book Closure For The Purpose Of EOGM
Pursuant to SEction 91 of Companies Act ,2013 and Reg 42 of SEBI (LODR),2015 the register of members and share transfer books will remain closed from 12th January,2024 to 18th January 2024 for purpose of EOGM. Fredun Pharmaceuticals Ltd - 539730 - Notice Of Extra Ordinary Geberal Meeting Of Fredun Pharmaceuticals Limited
Notice is hereby given that the EOGM of Fredun Pharmaceurticals Ltd will be held on Thursday January 18,2024 at 03:00 p.m IST through VC and OAVM Fredun Pharmaceuticals Ltd - 539730 - Extra-Ordinary General Meeting ('EOGM') Of The Members Of Fredun Pharmaceuticals Limited (The 'Company') Will Be Held On Thursday, January 18, 2024 At 03.00 P.M. IST Through Video Conferencing ('VC')/Other Audio Visual Means ('OAVM')
Extra- Ordinary General Meeting ("EOGM") of the Members of Fredun Pharmaceuticals Ltd (the "Company") will be held on Thursday, January 18,2024 at 03:00 P.M IST through Video Conferencing/ other Audio Visaul Means Fredun Pharmaceuticals Ltd - 539730 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Pursuant to Regulation 30 read with Schedule III Part A and Regulation 47 of SEBI(LODR),2015 please find enclosed herewith copies issued for attention of shareholders in respect of information regarding EOGM to be held on Thursday, January 18,2024 at 03:00 p.m through VC/AOVM and this regard published in the follwoing newspapers: 1. Business standard 2. Mumbai Laskadeep Fredun Pharmaceuticals Ltd - 539730 - Announcement under Regulation 30 (LODR)-Change in Management
Re-appointment of Dr. (Mrs) Daulat Medhora as a Whole time Director designated as Jt Managing Director for the period of 5 years w.e.f 31st December, 2023 Fredun Pharmaceuticals Ltd - 539730 - Board Meeting Outcome for Re-Appointment Of Whole Time Director Dr. (Mrs) Daulat Medhora W.E.F 31St December, 2023
We wish to inform you that the Board of Directors of Fredun Pharmaceuticals Limited (hereinafter referred to as 'the Company'), at their Meeting held on Thursday, December, 21 2023 had considered and approved the re-appointment of Dr. (Mrs) Daulat Nariman Medhora (DIN: 01745277) as the Whole time Director designated as Jt Managing Director of the Company for a further term of five years w.e.f. December 31, 2023 to December 30, 2028. The brief profile of Dr. (Mrs.) Daulat Medhora (DIN: 01745277) and disclosures as required is enclosed herewith as "ANNEXURE A'''. to this intimation. The Meeting of the Board Commenced at 06.00 P.M. and concluded at 06:20 P.M. Fredun Pharmaceuticals Ltd - 539730 - Announcement under Regulation 30 (LODR)-Raising of Funds
To consider a proposal for Fund raising upto Rs. 120 Crores by way of FPO, Right issue, ADR/GDR/FCCB, QIP, Debt Issue, Preferential issue or any other method in accordance with the provisions applicable.